Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001882909-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
16,125
Total Value
$465,002.09
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 2,500 | $27.50 | $68,750.00 | 44,853 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 1,250 | $22.40 | $28,000.00 | 46,103 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 1,625 | $20.46 | $33,247.50 | 47,728 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 4,275 | $62.13 | $265,627.12 | 43,453 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 800 | $62.85 | $50,278.48 | 42,653 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 15, 2026 | Sale | 300 | $63.66 | $19,098.99 | 42,353 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 1,250 | $0.00 | $0.00 | 3,750 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 1,625 | $0.00 | $0.00 | 17,875 | Direct | โ | View Details |